HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Status unconfirmed · Not applicable

Conditions studied: Homozygous Familial Hypercholesterolemia, HoFH

In brief

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Key facts

Study ID

NCT03135184

Run by

HDL Therapeutics

People needed

6

Starts

2018-01-26

Expected to finish

2019-08-01

Last updated by the study team

2019-05-23

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cedars-Sinai Medical Center (CSMC) — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.